05776456 is referenced by 187 patents and cites 7 patents.

Disclosed herein are therapeutic treatment protocols designed for the treatment of B cell lymphoma. These protocols are based upon therapeutic strategies which include the use of administration of immunologically active mouse/human chimeric anti-CD20 antibodies, radiolabeled anti-CD20 antibodies, and cooperative strategies comprising the use of chimeric anti-CD20 antibodies and radiolabeled anti-CD20 antibodies.

Title
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
Application Number
978891
Publication Number
5776456
Application Date
June 7, 1995
Publication Date
July 7, 1998
Inventor
William H Rastetter
Rancho Sante Fe
CA, US
Mitchell E Reff
San Diego
CA, US
Roland A Newman
San Diego
CA, US
John E Leonard
Encinitas
CA, US
Nabil Hanna
Olivenhain
CA, US
Darrell R Anderson
Escondido
CA, US
Agent
Burns Doane Swecker & Mathis
Assignee
IDEC Pharmaceuticals Corporation
CA, US
IPC
C07K 16/30
C07K 16/28
A61K 51/00
A61K 39/395
View Original Source